Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway

Cisplatin (DDP) is one of the first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC). However, repeated use of cisplatin in clinical practice often induces chemoresistance. The aims of this study were to investigate whether rosmarinic acid (RA) could reverse multidrug resistance (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Phytother Res
Hlavní autoři: Liao, Xiao‐Zhong, Gao, Ying, Sun, Ling‐Ling, Liu, Jia‐Hui, Chen, Han‐Rui, Yu, Ling, Chen, Zhuang‐Zhong, Chen, Wen‐Hui, Lin, Li‐Zhu
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd. 2020
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217221/
https://ncbi.nlm.nih.gov/pubmed/31985119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.6584
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky